Spinal Bone Graft Substitutes Market Analysis | Canada | 2016-2022 | MedCore

  • Year: 2016
  • Scope: 2012-2022
  • Region: Canada
  • Pages: 47
  • Published Date: 11/1/2016
  • Type: MedCore

Product Description

The vast majority of allograft materials utilized in spinal surgeries in Canada are supplied by large national tissue bank organizations and to a smaller extent, by provincial local tissue banks. In recent years, consolidation of tissue banks has become a growing trend as larger tissue organizations demonstrated abilities to develop more sophisticated and specialized allografts. Major allograft tissue banks in Canada include Mount Sinai Allograft Technologies and the Regional Tissue Bank. Local supply is limited to donor materials received at Canadian Tissue Banks such as Mount Sinai Hospital and the Regional Tissue Bank to a large extent. The majority of the allograft market is supplied domestically as it is simple for a Canadian tissue bank to source bone domestically and cut it up to provide cancellous or corticancellous chips or granules. Therefore, physicians do not feel it necessary to purchase proprietary allograft chips in the Canadian market and instead rely heavily on domestically sourced and distributed allograft. There is however a limited allograft bone graft market for spinal indications that is imported from U.S. sources, mainly from not for profit tissue banks like MTF.

FREE Sample Report

The "Canadian Market Report for Orthopedic Biomaterials 2016 - MedSuite" includes analysis on the following companies currently active in this market:
Wright Medical
Canadian Local Tissue Banks
RTI Surgical
Zimmer Biomet
Anika Therapeutics
Ferring Pharma
Aralez Pharma
IGEA Medical
Fintek Bio-Electric
BTT Melmak
ITO Company
Others include: Aptissen SA, Fidia Pharma, Mylan Institutional and TRB Chemedica.
Others include: Baxter, Davol, LifeNet Health, MTF, Novabone, OrthoVita, Smith & Nephew, etc.
*Not all companies are currently active in every segment or sub-report from this suite. For more details contact an iData Research Product Advisor.

iData’s 9-Step Research Methodology

Our reports follow an in-depth 9-step methodology which focuses on the following research systems:

  • Original primary research that consists of the most up-to-date market data
  • Strong foundation of quantitative and qualitative research
  • Focused on the needs and strategic challenges of the industry participants

Step 1: Project Initiation & Team Selection During this preliminary investigation, all staff members involved in the industry discusses the topic in detail.

Step 2: Prepare Data Systems and Perform Secondary Research The first task of the research team is to prepare for the data collection process: Filing systems and relational databases are developed as needed.

Step 3: Preparation for Interviews & Questionnaire Design The core of all iData research reports is primary market research. Interviews with industry insiders represent the single most reliable way to obtain accurate, current data about market conditions, trends, threats and opportunities.

Step 4: Performing Primary Research At this stage, interviews are performed using contacts and information acquired in the secondary research phase.

Step 5: Research Analysis: Establishing Baseline Estimates Following the completion of the primary research phase, the collected information must be synthesized into an accurate view of the market status. The most important question is the current state of the market.

Step 6: Market Forecast and Analysis iData Research uses a proprietary method to combine statistical data and opinions of industry experts to forecast future market values.

Step 7: Identify Strategic Opportunities iData analysts identify in broad terms why some companies are gaining or losing share within a given market segment.

Step 8: Final Review and Market Release An integral part of the iData research methodology is a built-in philosophy of quality control and continuing improvement is integral to the iData philosophy.

Step 9: Customer Feedback and Market Monitoring iData philosophy of continuous improvement requires that reports and consulting projects be monitored after release for customer feedback and market accuracy.

Click Here to Read More About Our Methodology

Explore Options

Report Summary


Select License Type

Bone graft substitute products are utilized by dentists/periodontitis, neurosurgeons and orthopedic surgeons. Orthopedic indications represent the most major portion of the bone graft substitute market, with spinal fusions representing the most major category of surgery within that realm. For the purpose of this report, we do not assess the dental bone graft substitute market in any way. Instead, we focus on spinal indications for bone grafts and its size relative to the bone graft substitute market (excluding dental indications).

  • 2016
  • 2012-2022
  • Canada
  • 11/1/2016
  • 47
  • MedCore
    Your Cart
    Your cart is emptyReturn to Report Library